sigma-tau is one of the most important Italian pharmaceutical groups, with a major presence also on the international stage. For more than half a century the company has been active in promoting the quality of life of man and his health. sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs. These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products. Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

Teika Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals products. They deliver higher-quality drugs, in pharmaceutical management and quality control standards Drop Pharmaceutical (GMP) to introduce the latest manufacturing equipment adapted to perform thorough manufacturing hygiene control. The company was founded in 1945 and is headquartered in Toyama City, Japan.

Sooft Italia SpA engages in the manufacture of ophthalmic products. It offers solutions for age-related macular degeneration, dry eye, eye hygiene, eye discomfort after surgery, and inflammatory and infectious diseases. Its products include Macular Fag, Protezione Retina, Luteinomega3, Luteim Omega 3 2, Macular Active, Lactoyal, Bluyal A, Blugel A, Blu Yal, Bluyal, Lutein Omega 3, Iridium Garze, Trium, and Combitimor. The company was founded by Marcello Stagni and Enrico Biondi in 2000 and is headquartered in Montegiorgio, Italy.

Manufactures and sells pharmaceuticals

Dompe Farmaceutici SpA operates as a biopharmaceutical company. It develops pharmaceutical and biotechnological drugs. The firm provides updating and scientific assistance services to doctors of general medicine, paediatrics, pneumology, otology, orthopaedics, rheumatology, physiatrist, odontology, accident and emergency and first aid stations. The company was founded by Franco Domp�� in 1940 and is headquartered in Milan, Italy.

Les h��pitaux universitaires de Gen��ve is a private company headquartered in Switzerland that operates hospitals.

JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following segments: Pharmaceutical Business; and Medical and Research Equipment Business. The Pharmaceutical Business segment deals with the manufacture, purchase, and sale of ethical drugs, active pharmaceutical ingredients, and raw materials. The Medical and Research Equipment Business segment sells medical devices and laboratory equipment. The company was founded by Shin Ashida on September 13, 1975 and is headquartered in Ashiya, Japan.

Kansai Technology Licensing Organization Co. Ltd. is a Japanese private company that provides technology transfer and research exchange services around the world.

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

Nishida KK is a private company headquartered in Japan involved in gasoline service stations.

S & S GmbH is a German private company located in Grosswallstadt that manufactures machine turned parts. The firm was founded in 1969 by Ernst Sender and Heinz Schmidt. Tino Schwarzkopf and Klaus Schwarzkopf are the current co-CEOs of the company.

Ningbo Star Technology Development Co., Ltd., established on 1997-09-28, Business scope includes general items:Optical Instrument Manufacturing;Optical Instrument Sales;Instrument Manufacturing;Instrument sales;Mechanical and electrical equipment manufacturing;Sales of mechanical and electrical equipment;Production of Class I Medical Devices;Sales of Class I Medical Devices;software development;software sales;Internet of things technology research and development;Internet of Things Technology Services;Manufacturing of computer software, hardware and peripheral equipment;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;internet sales(Except for products that require a license for sale);Import and export;Technology Import and Export;Import and export agency;Domestic trade agent;Sales of Class II Medical Devices;electronics sales;glasses sales(Contact lenses not included);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Information system integration service;Metering technical service;Intellectual Property Services(Except for patent agency services);rental service(Licensed rental services not included);Class II Medical Device Leasing;Class I Medical Device Leasing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Internet Information Service for Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

BONAC specializes in research and development of nucleic acid medicines. Its services include nucleic acid drug substance manufacturing and drug development. The company was founded in 2010.

Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd., established on 2003-12-18, Business scope includes licensed projects:pharmaceutical production;Drug retail;Drug Wholesale;Pharmaceutical commissioned production;Cosmetic production;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Production of hygiene products and single-use medical products;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Manufacturing of medical packaging materials;Sales of packaging materials and products;Cosmetics Wholesale;Cosmetics Retail;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Import and export;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Keyu United Stem Cell Biotechnology Co., Ltd., established on 2006-04-21, Business scope includes technology development,technology transfer,Technical Services,Information Consulting;Import and export,Technology Import and Export,Agent import and export.(non-patent technology investment125ten thousand yuan;the enterprise2006year04moon21Currently a domestic enterprise,At2006year04moon21Changed to a foreign-invested enterprise.)